Internship

Internship

Undergraduate Translational Medicine Research Team, Solid Tumor Oncology

Posted on 11/1/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Cambridge, MA, USA

Role may require onsite presence as per occupancy structure.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • BS candidate with relevant coursework and background in a life sciences discipline.
  • Hands-on experience in laboratory research in biological sciences or biochemistry.
  • Experience with experimental data and techniques related to genomics, proteomics, flow cytometry, immunohistochemistry, and/or histology is highly desirable.
  • Must be organized and able to work well in a team setting.
  • Excellent communication skills, both written and verbal are required.
Responsibilities
  • Engage with team leads to learn about an asset program and technology platforms used in the group
  • Conduct relevant literature reviews and summarize for the team
  • With supervision, define a research hypothesis and test experimentally using existing datasets and/or participate in novel data generation
  • Present research findings to the team and cross functional leaders as part of the BMS Internship Program

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and cardiovascular conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with AI Proteins could lead to significant revenue from miniprotein-based therapeutics.
  • FDA approval of Opdivo enhances BMS's leadership in lung cancer treatment.
  • Introduction of Cobenfy positions BMS to capture the psychiatric drug market.

What critics are saying

  • Legal challenges with the 340B Program may affect BMS's pricing strategies.
  • The $6.4 billion lawsuit by UMB could result in financial liabilities.

What makes Bristol-Myers Squibb unique

  • BMS focuses on innovative treatments in oncology, immunology, and cardiovascular diseases.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE